PMID: 35344579

Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia.

Blood
Bellusci, Lorenza L, Grubbs, Gabrielle G, Srivastava, Pragya P, Nemeth, Michael J MJ, Griffiths, Elizabeth A EA, Golding, Hana H, Khurana, Surender S
2022-05-05

16 variants were identified in this publication


Variant ID Gene cDNA Protein Consequence Exon Intron
5-170818735-C-T NPM1 c.284C>T p.T95I Missense 4/11 -
17-38172490-C-T CSF3 c.200C>T p.A67V Missense 3/5 -
20-31019142-G-T ASXL1 c.737G>T p.R246I Missense 9/13 -
7-73442593-C-T ELN c.76C>T p.P26S Missense 1/33 -
7-73474287-G-A ELN c.1486G>A p.G496S Missense 23/33 -
13-28608502-G-T FLT3 c.1640C>A p.T547K Missense 13/24 -
9-5126744-G-C JAK2 c.3352G>C p.D1118H Missense 25/25 -
9-5123024-C-T JAK2 c.3080C>T p.T1027I Missense 23/25 -
13-28578228-C-A FLT3 c.2943G>T p.L981F Missense 24/24 -
9-5050689-C-G JAK2 c.472C>G p.R158G Missense 6/25 -
5-170815004-C-T NPM1 c.52C>T p.L18F Missense 1/11 -
20-31021451-G-A ASXL1 c.1450G>A p.E484K Missense 12/13 -
20-31021452-A-C ASXL1 c.1451A>C p.E484A Missense 12/13 -
20-31022557-CG-AT ASXL1 c.2042_2043delCGinsAT p.P681H Missense 13/13 -
13-28578228-C-G FLT3 c.2943G>C p.L981F Missense 24/24 -
20-31022557-C-G ASXL1 c.2042C>G p.P681R Missense 13/13 -